The Impact of Diabetes Mellitus and Corresponding HbA1c Levels on the Future Risks of Cardiovascular Disease and Mortality: A Representative Cohort Study in Taiwan

@article{Chen2015TheIO,
  title={The Impact of Diabetes Mellitus and Corresponding HbA1c Levels on the Future Risks of Cardiovascular Disease and Mortality: A Representative Cohort Study in Taiwan},
  author={Yun-yu Chen and Yenn-Jiang Lin and Eric Chong and Pei-Chun Chen and Taz-Fan Chao and Shih-Ann Chen and Kuo-Liong Chien},
  journal={PLoS ONE},
  year={2015},
  volume={10}
}
Background This study explored the relationship between the glycated hemoglobin (HbA1c) level in patients with or without diabetes mellitus and future risks of cardiovascular disease and death. Methods Based on a national representative cohort, a total of 5277 participants (7% with diabetes) were selected from Taiwan's Triple High Survey in 2002. The comorbidities, medication usages, and outcomes of cardiovascular disease and death, were extracted from the Taiwan’s National Health Insurance… Expand
Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study
TLDR
In a large general-practice cohort of patients with diabetes, uncontrolled glucose levels were associated with a substantial mortality and cardiovascular disease burden and a linear and increasingly positive dose-response of HbA1c levels and CHD hospitalization. Expand
Baseline glycemic status and mortality in 241,499 Korean metropolitan subjects: A Kangbuk Samsung Health Study.
TLDR
Mortality risk from all causes and cancer significantly increased in diabetes subjects regardless of the glucose control status, and in subjects not taking anti-diabetic medications, both high and low HbA1c resulted in increased risk for all-cause mortality. Expand
The long-term effectiveness of metabolic control on cardiovascular disease in patients with diabetes in a real-world health care setting - A prospective diabetes management study.
TLDR
Average levels of HbA1c, SBP, and triglycerides during follow-up were positively associated with the risk of CVD, and treatment targeting multiple factors can significantly reduce CVD risk. Expand
Diabetes control: Incidence of acute myocardial infarction and all-cause mortality among patients with 3–6 years’ disease duration
TLDR
HbA1c concentration below 6.0% may be associated with an excess risk for all-cause mortality, and Clinicians must be aware of this association when treating individual patients. Expand
Correlation of Glycosylated Hemoglobin and Complexity of Coronary Artery Disease among Aged ≥45 Years Population with Diabetes Mellitus
TLDR
The HbA1c is insignificantly correlated with the complexity of coronary artery disease in diabetic patients having age more than 45 years, while only two factors, hypertension and increased triglycerides are significantly different among the Hb a1c groups. Expand
Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA)
TLDR
Given the approximate J-shaped association between type 1 diabetes duration and CVD, the impact of cardiovascular risk stratification and management before and after 20 years duration needs to be further assessed longitudinally. Expand
Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta‐Analysis
TLDR
A rising HbA1c level is associated with increased first‐ever stroke risk in cohorts with a diabetes mellitus diagnosis and increased risk of first-ever ischemic stroke in non–diabetes mellitus cohorts, and the findings suggest that more intensive Hb a1c glycemic control targets may be required for optimal isChemic stroke prevention. Expand
Age-related differences in glycaemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: a cross-sectional study from the Australian National Diabetes Audit
TLDR
Younger age was associated with poorer glycaemic control and adverse cardiovascular risk factor profiles and it is imperative to optimise and monitor treatment in order to improve long-term outcomes. Expand
Association of baseline as well as change in lipid levels with the risk of cardiovascular diseases and all-cause deaths
TLDR
Baseline and changes in total cholesterol, triglycerides, and LDL-C levels were positively associated with the risk of cardiovascular diseases, whereas baseline and changes of total cholesterol and LDL -C and non-high-density lipoprotein cholesterol levels were inversely associated with all-cause deaths. Expand
Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China
TLDR
Assessment of how well low-density lipoprotein cholesterol (LDL-C) was managed in Nanjing community hospitals, China found only a small portion of patients achieved target HDL-C level, and the rate of using statins to control LDL-C was low. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 33 REFERENCES
HbA1c and the Risks for All-Cause and Cardiovascular Mortality in the General Japanese Population
TLDR
High HbA1c levels were associated with increased risk for all-cause mortality and death from CVD, coronary heart disease, and cerebral infarction in general East Asian populations, as in Western populations. Expand
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
TLDR
Low and high mean HbA(1c) values were associated with increased all-cause mortality and cardiac events, and diabetes guidelines might need revision to include a minimum HBA( 1c) value. Expand
Higher Glycated Hemoglobin Level Is Associated with Increased Risk for Ischemic Stroke in Non-Diabetic Korean Male Adults
TLDR
Higher HbA1c indicated a significantly increased risk for ischemic stroke after adjusting for other confounding variables in non-diabetic Korean adult males. Expand
Association of cardiovascular events with glycosylated haemoglobin in diabetic patients.
TLDR
Glycosylated haemoglobin is associated with cardiovascular events and myocardial infarction but not stroke in diabetic patients and this study was a case control study. Expand
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis
TLDR
There is an independent progressive relationship between indices of glycaemia and incident CV events, renal disease and death and clinical trials of glucose lowering to prevent these outcomes in diabetic and non-diabetic individuals are indicated. Expand
Glycated hemoglobin measurement and prediction of cardiovascular disease.
TLDR
The improvement provided by HbA1c assessment in prediction of CVD risk was equal to or better than estimated improvements for measurement of fasting, random, or postload plasma glucose levels. Expand
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.
TLDR
G glycated hemoglobin was similarly associated with a risk of diabetes and more strongly associated with risks of cardiovascular disease and death from any cause as compared with fasting glucose, and measures of risk discrimination showed significant improvement when glycated Hemoglobin was added to models including fasting glucose. Expand
Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.
TLDR
Among patients with diabetes who were receiving metformin, the addition of insulin vs a sulfonylurea was associated with an increased risk of a composite of nonfatal cardiovascular outcomes and all-cause mortality. Expand
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
TLDR
In patients with type 2 diabetes the risk of diabetic complications was strongly associated with raised blood pressure, with the lowest risk being in those with systolic blood pressure less than 120 mm Hg. Expand
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
TLDR
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Expand
...
1
2
3
4
...